Forecast & Rating4 analysts currently cover Atara Biotherap, of which 3 give a positive rating. The average price target is $13.67, about 53.6% upside from the current price of $8.90. Coverage is limited, so the data is for reference only. Data as of Aug 21, 2026; this does not constitute investment advice.
Aug 21, 2026Price forecast
$13.6753.56%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 30, 2026
Forecast met21.8%
Stock price$8.90
Avg. target$19.0
High target$25
Low target$16
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.